1. Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase
- Author
-
Thomas Kroll, Emerita Mendoza Rengifo, Dimosthenis Sokaras, Ingrid J. Pickering, Natalia V. Dolgova, Qing Cheng, Susan Nehzati, Graham N. George, and Elias S.J. Arnér
- Subjects
inorganic chemicals ,Antioxidant ,Auranofin ,medicine.medical_treatment ,Thioredoxin reductase ,chemistry.chemical_element ,010402 general chemistry ,01 natural sciences ,Inorganic Chemistry ,chemistry.chemical_compound ,Thioredoxins ,Thioredoxin Reductase 1 ,medicine ,Animals ,Physical and Theoretical Chemistry ,chemistry.chemical_classification ,Reactive oxygen species ,Binding Sites ,Selenocysteine ,010405 organic chemistry ,Methylmercury Compounds ,Rats ,0104 chemical sciences ,3. Good health ,Enzyme ,chemistry ,Biochemistry ,Selenium ,medicine.drug - Abstract
Selenoenzymes, containing a selenocysteine (Sec) residue, fulfill important roles in biology. The mammalian thioredoxin reductase selenoenzymes are key regulators of antioxidant defense and redox signaling and are inhibited by methylmercury species and by the gold-containing drug auranofin. It has been proposed that such inhibition is mediated by metal binding to Sec in the enzyme. However, direct structural observations of these classes of inhibitors binding to selenoenzymes have been few to date. Here we therefore have used extended X-ray absorption fine structure as a direct structural probe to investigate binding to the selenium site in recombinant rat thioredoxin reductase 1 (TrxR1). The results demonstrate for the first time the direct and complete binding of the metal atom of the inhibitors to the selenium atom in TrxR1 for both methylmercury and auranofin, indicating that TrxR1 inhibition indeed can be attributed to such direct metal-selenium binding.
- Published
- 2020
- Full Text
- View/download PDF